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Abstract: Detection of atherosclerotic plaque vulnerability has critical 
clinical implications for avoiding sudden death in patients with high risk of 
plaque rupture. We report on multimodality imaging of ex-vivo human 
carotid plaque samples using a system that integrates fluorescence lifetime 
imaging (FLIM), ultrasonic backscatter microscopy (UBM), and 
photoacoustic imaging (PAI). Biochemical composition is differentiated 
with a high temporal resolution and sensitivity at the surface of the plaque 
by the FLIM subsystem. 3D microanatomy of the whole plaque is 
reconstructed by the UBM. Functional imaging associated with optical 
absorption contrast is evaluated from the PAI component. Simultaneous 
recordings of the optical, ultrasonic, and photoacoustic data present a wealth 
of complementary information concerning the plaque composition, 
structure, and function that are related to plaque vulnerability. This 
approach is expected to improve our ability to study atherosclerotic plaques. 
The multimodal system presented here can be translated into a catheter 
based intraluminal system for future clinical studies. 
©2011 Optical Society of America 
OCIS codes: (170.6510) Spectroscopy, tissue diagnostics; (300.6500) Spectroscopy, time-
resolved; (110.7170) Ultrasound; (170.5120) Photoacoustic imaging; (170.6935) Tissue 
characterization. 
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1. Introduction 
Atherosclerotic cardiovascular disease (ACVD), a progressive disease of arteries, is one of the 
major causes of death worldwide [1]. Current techniques for investigation of atherosclerotic 
plaques include angiography, intravascular magnetic resonance imaging (MRI), optical 
coherence tomography (OCT) [2], intravascular ultrasound (IVUS) [3], optical spectroscopy 
(NIR, Raman, and fluorescence spectroscopy) [4,5], and photoacoustic imaging (PAI) [6]. 
However, a single imaging technique can only provide an incomplete characterization of the 
lesion. More complete information concerning various markers involved in plaque 
vulnerability and rupture is needed for improving plaque evaluation [7]. Typically these 
markers encompass diverse features derived from plaque structure, composition, and function 
(e.g. thinning of the fibrous cap, large lipid-rich pool, macrophage presence and activity 
within fibrotic cap, and outward remodeling). 
This pilot study investigates whether compositional, structural, and functional 
characteristics of human atherosclerotic plaques can be evaluated concurrently via a flexible 
scanning probe composed of a single fiber-optic and a single-element high-frequency 
ultrasonic transducer. This configuration facilitates integration of three distinct diagnostic 
modalities: fluorescence lifetime imaging (FLIM), ultrasonic backscatter microscopy (UBM), 
and photoacoustic imaging (PAI), and acquisition of rigid-linked co-registered data for 
characterization of human atherosclerotic plaque. FLIM has demonstrated potential for 
characterization and mapping of the biochemical composition of the fibrotic cap within the 
superficial layer (~250 µm deep under UV excitation) and for distinguishing plaque features 
within this cap that have been related to plaque vulnerability [8,9]. UBM employs high-
frequency ultrasonic transducers (>40 MHz) that enable imaging of plaque microanatomy and 
morphology with high resolution (~50 µm) and penetration depth up to 4-5 mm [10]. UBM is 
applied to intravascular setting via IVUS rotational catheter. IVUS systems operating at 
frequencies greater than 40 MHz have been used in patients for the analysis of arterial wall 
morphology [11]. PAI can map the differences in optical absorption of various molecular 
constituents of tissues. More recently, PAI has been suggested as a complementary technique 
to IVUS and investigated as a potential modality for detection of vulnerable plaques [12]. PAI 
showed potential to resolve the lipid-rich from collagen-rich regions based on the distinct 
optical absorption signature of these components. In this context, the technique reported here 
combining FLIM, UBM and PAI is expected to provide complementary information regarding 
features of atherosclerotic plaques, specifically those that are potential predictors of plaque 
rupture. 
While this study focuses on evaluating the ability of the hybrid (optical-ultrasonic) system 
to record via a compact probe multimodal data by linear-scanning, the approach reported here 
can be used intravascularly through a modified IVUS catheter that enables rotational-
scanning. Engineering efforts integrating IVUS and fiberoptics as one catheter have been 
previously reported [13,14]. 
2. Materials and Methods 
The multimodal imaging device included the following components: (1) a fast-speed time-
resolved fluorescence spectroscopy (TRFS) device capable of simultaneously recording 
fluorescence decay characteristics in multiple spectral bands and allowing for 
dynamic/continuous recording of fluorescence signals that could be reconstructed into FLIM 
images [15,16]; (2) a UBM subsystem designed for working with high-frequency single-
element ultrasonic transducers; (3) a PAI subsystem sharing the electronics and the ultrasonic 
data acquisition pathway with the UBM subsystem and the illumination portion with the 
TRFS subsystem. Concurrent application of the three modalities was achieved using a hybrid 
imaging probe integrating coaxially a 600 µm silica optical fiber for fluorescence excitation-
collection and delivery of light for PAI and a press-focused ultrasonic transducer for UBM 
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imaging and PAI signal detection [17]. Sample scanning was achieved via an XYZ-motorized 
stage (1 µm positioning accuracy) that permitted translation and positioning of the hybrid 
probe above the atherosclerotic plaque specimen. The setup allowed sequential acquisition of 
co-registered FLIM-UBM-PAI images. A detailed description and a complete 
characterization/validation of this multimodal imaging system will be reported separately 
(manuscript in preparation). Here, we limit ourselves to briefly describing the system 
specifications relevant to the current study of atherosclerotic plaques. 
2.1 FLIM Subsystem 
Fluorescence was induced by a pulsed nitrogen laser (337 nm, 0.7 ns) and detected via a gated 
MCP-PMT (180 ps rise time) and a fast digitizer (2.5 GHz bandwidth, 20 Gsamples/s). The 
rapid acquisition enabled 2D dynamic recording (scanning speed 0.2 mm/s) of time-resolved 
fluorescence from a tissue area of interest that in turn enabled the reconstruction of a set of 
fluorescence lifetime images in multiple spectral bands. The lifetime was defined as the 1/e 
decay time of the fluorescence impulse response from the tissue that was retrieved via 
analytical models and Laguerre deconvolution algorithms [18]. For the current studies, the 
fluorescence emission was acquired and analyzed for three emission bands: 390 ± 20 nm; 450 
± 23 nm; and 540 ± 25 nm. These wavelength bands are sensitive to endogenous fluorophores 
within the vessel walls such as collagen, elastin, and lipid components. Individual 
fluorescence lifetime values for each scanning line were analyzed in both spectroscopic-
format (in order to determine the plaque composition at each location), and in image-format 
(to determine the plaque composition within a relatively larger area). In the FLIM image, the 
sample area for data acquisition was defined by the fluorescence excitation-collection 
geometry, laser repetition rate and probe scanning speed. Specifically, in the current 
experiment, the pixel size of the image was 82 µm in the lateral scanning direction (x), and 
200 µm between frames (y). A 2D map of fluorescence lifetime of tissue was thus generated 
via the same device without the need of a time-gated imaging camera typically used in 
conventional fluorescence lifetime imaging microscopy systems [19]. The prospect of 
analyzing plaque composition for large areas via FLIM and determination of the extent of 
lipid-rich areas is important in diagnosing plaque at high-risk of rupture. 
2.2 UBM Subsystem 
The UBM component used a 41 MHz transducer (6 mm focal depth, 70% bandwidth, 3.75 
mm aperture size) and provided ultrasound images with an axial resolution of 37 µm and 
lateral resolution of 65 µm [20]. Ultrasonic backscatter signals were detected by the 
transducer, amplified with a low noise amplifier by 35 dB, and recorded by a digitizer with a 
sampling rate of 400 M samples/s). Tomographic ultrasonic data were acquired by using the 
XYZ positioning stage at an acquisition speed in a few minutes. The dimension of the 
measurement cell was 0.02 (lateral, x) × 0.2 (between scanning frames, y) × 0.002 (in depth, 
z) mm
3
. The grey scale cross-sectional UBM images with structure segmentation were 
analyzed at every plane of interest and correlated with the spectroscopic signals or images. An 
intensity calibration curve as a function of depth was measured and used to compensate the 
intensity variations across the focal region of the ultrasound field. 
2.3 PAI Subsystem 
The PAI component was developed based on minimal modification of the configuration of the 
FLIM-UBM system. The fiberoptic probe used for fluorescence excitation/collection was 
coupled to a frequency doubled pulsed Nd: YAG laser (532 nm, 10 ns, and average fluence of 
10 mJ/cm
2
) to induce photoacoustic effect [6]. PAI data was acquired via the UBM transducer 
and receiving circuit by minor modification of the acquisition software. The imaging 
resolution of the PAI subsystem was 50 µm and 70 µm in axial and lateral direction, 
respectively. Although the PAI and UBM shared the same transducer for receiving the echoes, 
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the two imaging systems had different spatial resolution. This difference was because the PAI 
resolution was determined not only by the transducer but also by the frequency characteristics 
of the photoacoustic response (affected by the absorber size and the laser pulse width [21]. 
The dimension of the PAI measurement cell was 0.02 (x) × 0.2 (y) × 0.004 (z) mm
3
. The 
acquisition speed of the PAI data was 75 s/frame due to the low repetition rate (10 Hz) of the 
laser source. It was straightforward and feasible adding the PAI subsystem to the bimodal 
approach (FLIM-UBM) and transforming into a tri-modal system (FLIM-UBM-PAI) for 
arterial plaque characterization/diagnosis. 
2.4 Tissue Samples and Histological Preparation and Analysis 
Multimodal imaging was conducted in human carotid atherosclerotic plaque samples within 
two hours of endarterectomy. Multimodal measurements from two human carotid plaque 
samples were acquired. After multimodal scanning, the orientation of the tissue specimen and 
location of the imaged region were marked with tissue ink and the sample was fixed in 10% 
formalin, embedded in paraffin, and processed routinely. Four micron tissue sections were 
stained with hematoxylin and eosin (H&E) and a combined trichrome/elastin method (mature 
collagen stained blue, elastin stained black and smooth muscle cells stained red). The 
histological results were used as a gold standard to correlate and validate the multimodal data. 
2.5 Image Processing and Co-Registration 
In the integrated probe, the UBM/FLIM portions are mechanically fixed with respect to the 
optical component. The transformation between the two images is therefore rigid. The offset 
of the optical fiber from the UBM transducer was directly measured and the corresponding X 
and Y translations (0.5 mm and 0.1 mm respectively) were applied to the images for overlay. 
No rotation of one system with respect to the other is possible in the setup. The UBM and the 
PAI portions are also mechanically fixed with respect to each other. Therefore, for co-
registering the two types of 3D data, only rigid transformation parameters needed to be 
estimated. We fabricated a grid phantom from carbon fibers (thickness: ~20 μm) for 
measuring the six parameters of the rigid transformation. The thin carbon fibers showed 
excellent contrast for both UBM and PAI and provided means for determining the 
transformation at close to the spatial resolution of both systems. The phantom was first 
mechanically held horizontally in water along the focal plane of the system and underwent 3D 
scanning by UBM and PAI. 3D image matrices of reconstructed UBM and PAI were created 
with appropriate voxel dimensions. Mutual information-based rigid registration [22] was then 
carried out between the two imaging data sets and transformation parameters (translations: 
0.15, 0.9 and 0.5 mm in the X, Y and Z directions respectively, no rotational offsets) were 
recorded. The phantom was translated vertically for 2 mm on either side of the focal plane in 
steps of 250 μm and rescanned using both UBM and PAI. The task of rigid registration was 
repeated at each position. Only negligible differences (<10 μm) were observed in the 
registration parameters. The parameters determined through this process were used to 
generate the results shown in this paper. 
3. Results 
3.1 Multimodal Measurements from Ex-Vivo Carotid Plaque 
A representative example was used to demonstrate the ability of the multimodal system to 
retrieve complementary characteristics from the atherosclerotic plaque [Fig. 1]. The 
transducer-fiberoptic integrated probe used for the examination is shown in Fig. 1(b). The 
fluorescence lifetime map acquired in three wavelength bands showed (1) the compositional 
changes at the lumen-surface of the plaque at specific wavelength bands, and (2) the changes 
of the trend of the lifetime along wavelengths for each type of composition [Fig. 1(c)–1(e)]. 
Both these variations were used to characterize plaque composition. For the 390 nm channel 
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[Fig. 1(c)], the average lifetime values within three regions of interest (ROI) were compared 
against histopathological results that are independently from the multimodal measurement. 
The plaque type in the cyan circle area was determined to be collagen-rich fibrotic plaque 
from histology. From FLIM, a longer average lifetime of 3.12 ± 0.02 ns was observed, 
compared with the relatively normal area (magenta circle) that exhibited relatively shorter 
average lifetime of 2.0 ± 0.01 ns. The area shown by the black circle had mixed composition 
(collagen and lipids), as indicated by histology, and showed an average lifetime of 2.48 ± 0.01 
ns. The histograms of the lifetime values of the three locations are compared in Fig. 1(f). By 
observing the lifetime over the three wavelength bands [Fig. 1(c)–1(e)], the normal area 
showed a slightly increased lifetime from 2.0 ns to 2.41 ns when the wavelength increased 
from 390 nm to 540 nm. In comparison, a different trend in the fibrous region (cyan circle) 
was observed where the lifetime decreased from 3.12 ns to 2.55 ns with the increasing 
wavelength. UBM images for each transverse plane were acquired from the investigated 
region to form a fully 3D volumetric data set. Surface renderings of the UBM volume with 
representative orthogonal planes are shown in Fig. 1(g) and 1(h). The co-registered FLIM data 
was mapped on top of the UBM volume data showing the surface composition changes of the 
plaque [Fig. 1(i)]. In this manner, biochemical composition of the plaque surface (i.e. the 
vessel lumen) was characterized by FLIM, and simultaneously anatomical information of the 
cross section at deeper locations was reconstructed from UBM. 
 
Fig. 1. Representative co-registered FLIM and UBM measurements of a human carotid plaque 
sample. (a) Photo of the carotid plaque sample with the imaging area outlined by the red 
dashed line (12.2 mm x 4 mm). (b) The combined probe integrating an ultrasonic transducer 
and an optical fiber. (c)-(e) FLIM images overlaid on top of the plaque photo at three different 
wavelengths, where the color represented average lifetime values from 0 ns to 4 ns for each 
pixel. Three regions were labeled in (c) and analyzed (f) Histogram of the average lifetime 
values at 390 nm from the three regions in (c) corresponding to three tissue types (IT: intimal 
thickening, FL: fibro-lipidic plaque, and FP: fibrotic plaque). (g)-(h) 3D UBM volume data 
from the investigated region (12.2 x 4 x 2 mm3). Surface renderings of the UBM volume with 
orthogonal planes are shown with 45 dB displaying dynamics range and jet color map. (i) 
FLIM map at 390 nm coregistered with and overlaid onto a 3D UBM volume rendering. The 
minor differences in color scale between (c) and (i) are a by-product of 3D rendering. The PAI 
data can be displayed similarly but is not shown here to simplify the figure. 
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3.2 Correlation and Analysis of the Multimodal Measurements 
In order to demonstrate the advantages provided by each modality and to show how the three 
modalities complemented each other, detailed analysis of the multimodal data is summarized 
in Fig. 2. The regions spanned by four ROIs are shown in Fig. 2(a) and the mean lifetime 
value was averaged over the sampling number within each region. Histopathological analysis 
concluded that ROI-1 corresponded to intimal thickening, ROI-2 showed fibro-lipidic plaque 
with calcific deposits, ROI-3 showed intimal thickening, and ROI-4 indicated fibrotic plaque 
[arrows in Fig. 2(e)]. 
 
Fig. 2. Multimodal measurements and correlation analysis with histology from the scanning 
position indicated by the black dashed line in Fig. 1(c). (a) Plots of the average lifetime as a 
function of scanning position. Four ROIs were analyzed to show the changes in lumen-surface 
composition. (b) Transverse UBM images from the same position as (a) showed the 
reconstruction of the plaque structure, where an acoustic shadowing area indicated calcific 
deposits. (c) The PAI image provided optical absorption contrast and structural information. 
HS: hot spot. (d) Co-registered UBM and PAI images were fused as one combined image. (e) 
The corresponding trichrome stained tissue section. (f)-(k) Zoomed-in histological images of 
the regions labeled with HS1 to HS4 in (c): (f) HS1, trichrome staining showing fibro-lipidic 
plaque and calcification. Macrocalcification, and microcalcification deposits (tens of microns) 
were observed (dark blue circles), (g) HS1, H&E staining confirming the microcalcification, 
(h) HS2, trichrome staining demonstrating the fibrotic collagen-rich region (blue lines) and 
lipid-rich area underneath (white clefts), (i) HS2, H&E, (j) HS3, dense fibrotic knot and intimal 
thickening with elastin fibers (black lines) and smooth muscle cells (red), and (k) HS4, knot of 
collagen fibers. 
In Fig. 2(a), different tissue types showed distinct average lifetime values at each channel 
and trends that varied as a function of wavelength. At 390 nm, the average lifetimes of the 
ROIs were: 2.03 ± 0.02 ns, 2.48 ± 0.02 ns, 2.09 ± 0.02 ns, and 3.0 ± 0.05 ns, respectively. The 
four regions were also differentiable by the trends of the average lifetime over wavelength. 
For example, with increasing wavelength, the lifetime increased from 2.09 to 2.40 ns (15%) 
for the intimal thickening composition in ROI-3 (similar trend in ROI-1) and decreased from 
3.0 to 2.57 ns (17%) for the fibrotic plaque in ROI-4. 
Transverse UBM grey scale images, from the same location as where the fluorescence data 
was acquired, demonstrated anatomical structures based on acoustic contrast [Fig. 2(b)]. The 
UBM image reconstructed the structure of the cross section of the plaque and showed obvious 
delineation of the intimal and medial layers. Thickened intima at the top of the tissue cross-
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section corresponded to the intimal thickening regions in ROIs 1 and 3. The hyperechoic 
region and acoustic shadowing within the thick fibrous cap in ROI 2 indicated calcific 
deposits. These features were also validated by histopathological analysis of the sample. 
Simultaneously acquired PAI maps provided optical absorption properties of the plaque 
sample [Fig. 2(c)]. The fused UBM-PAI image in Fig. 2(d) allowed the analysis of the 
photoacoustic response from the carotid artery sample within the anatomical delineation of the 
plaque reconstructed by the UBM image. The UBM-PAI image shows ultrasound echo and 
photoacoustic signal correlation in the fibrotic/calcific regions of the plaque. The low-
amplitude photoacoustic signal presented at the plaque-media boundary was also observed in 
the UBM images. Within this specimen, complex compositions were observed including 
collagen fibers, lipids, calcification, elastin fibers, and microvessels that could all act as 
optical absorbers [Fig. 2(e)]. Four regions with relatively large photoacoustic signal (“hot 
spots” (HS1-HS4)) were delineated from Fig. 2(c) and compared against histology. Higher 
magnitude of photoacoustic signals appeared to come from fibrotic regions (majorly 
comprised of collagen fibers, HS2) or regions with calcification or microcalcification deposits 
(HS1) than areas with more lipids (circle area in HS2). A dense knot of collagen-rich tissue 
observed at HS3 and HS4 also led to an increase of overall photoacoustic response compared 
to the surrounding area [Fig. 2(j), 2(k)]. Correlated features retrieved from FLIM, UBM and 
PAI within four ROIs indicated in Fig. 3 were summarized in Table 1. The values are reported 
as mean ± standard error. 
Table 1. Quantification of the Multimodal (FLIM-UBM-PAI) Data for Plaque 
Characterization (4 Locations) 
Region scanning 
distance/ 
Modality 
ROI-1 
1.1 – 3.0 mm 
ROI-2 
3.0 – 8.1 mm 
ROI-3 
8.1 – 11.4 mm 
ROI-4 
11.4 – 11.8 mm 
FLIM (lifetime - ns) 
390 nm 
450 nm 
540 nm 
2.03 ± 0.02 
2.19 ± 0.01 
2.26 ± 0.04 
2.48 ± 0.02 
2.45 ± 0.02 
2.53 ± 0.03 
2.09 ± 0.02 
2.24 ± 0.01 
2.40 ± 0.01 
3.0 ± 0.05 
2.63 ± 0.05 
2.57 ± 0.01 
UBM: 
Image evaluation 
Main features 
Delineation 
of intima and 
media layers 
Hypoechoic & 
acoustic 
shadowing 
Delineation of 
intima and media 
layers 
Thickened 
fibrotic cap 
PAI: 
Feature evaluation 
Hot spot 
(artifact from 
sample 
holding pin) 
High PA 
intensity 
& hot spots 
Delineation of 
intima and media 
layers & hot 
spots 
Moderate PA 
intensity from 
fibrous cap 
Histology Thin–intima 
elastin–rich 
media 
Heterogenous 
composition 
(collagen, lipids, 
calcification) and 
microstructure 
Thin–intima 
elastin–rich 
media 
Collagen-rich 
area 
Lifetime (ns) 
features in 
literature* [23] 
Intima 
thickening 
1.9-2.0 
Fibro–lipidic 
plaque 
2.4-2.5 
Intima thickening 
1.9-2.0 
Fibrotic plaque 
2.6-3.0 
*Average fluorescence lifetime values at 390 nm. 
A second scanning multimodal measurement from a different region as in Fig. 1 but from the 
same human carotid plaque was summarized in Fig. 3. This sample included three regions, 
histologically characterized as (from left to right): inflammation with macrophages, fibrotic-
calcific, and fibrotic plaque [Fig. 3(d) arrows]. The average lifetimes in the 540 nm filter band 
were: 1.24 ± 0.03 ns, 1.35 ± 0.03 ns, and 1.86 ± 0.03 ns, respectively [Fig. 3(a)]. The lifetime 
decreased 50% for lipid-rich regions in ROI-1 compared with the fibrotic plaque in ROI-3 at 
this long wavelength. These results are in agreement with our earlier publication on the time-
resolved fluorescence characteristics of carotid plaques [23]. The UBM image showed an 
increased hyperechoic region for both the calcific necrotic core under the fibrotic plaque in 
ROI-2 and dense collagen fibrotic region in ROI-3 [Fig. 3(b)]. The region in ROI-1 exhibited 
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a hypoechoic region corresponding to the inflammation area with macrophages. These 
features were also validated by histopathological analysis of the sample. The PAI image from 
the same location showed increased photoacoustic regions in ROI-2 and ROI-3 corresponding 
to the calcific and fibrotic region due to high scattering, which was consistent with the results 
in Fig. 2 [Fig. 3(c)]. The fused UBM and PAI image was shown in Fig. 3(d). 
 
Fig. 3. Example of the multimodal measurements from a different scanning location of the 
carotid plaque sample and data correlation. (a) Plots of the average lifetime as a function of 
scanning position. Three ROIs were analyzed to show the changes in surface composition. (b) 
Transverse UBM images from the same position as (a) showed the reconstruction of the plaque 
structure, where an acoustic shadowing area indicated calcific deposits. (c) The PAI image 
provided optical absorption contrast. (d) Co-registered UBM and PAI images were fused as one 
combined image. (e) The corresponding trichrome stained tissue section. (f)-(k) Zoomed-in 
histological images of the regions labeled with arrows in (e): (f) and (i) 
inflammation\macrophages, (g) fibrotic-calcific region using the trichrome stain, (j) H&E 
staining confirming the presence of calcification, (h) and (k) fibrotic plaque, respectively 
4. Discussion and Conclusions 
The multimodal system reported here showed the ability to provide a wealth of data that is 
complementary for the characterization of atherosclerotic plaque. Importantly, this data can be 
obtained through an integrated and compact scanning probe that allows for acquisition of co-
registered data from a plaque/tissue volume and display (1D, 2D, or 3D) of these data based 
on distinct diagnostic needs. For example (Fig. 1) 3D-UBM and PAI images acquired from a 
relatively large plaque volume can be co-registered with a 2D-FLIM map at the lumen-surface 
of this volume to provide a qualitative assessment of the distribution of distinct structural and 
compositional features of the plaque. In addition (Figs. 2 and 3) specific 1D (line-scanning) of 
fluorescence data and the corresponding 2D UBM and PAI transverse images can be also 
extracted from the interrogated volume. Such subset of data enables a more quantitative 
interpretation of fluorescence emission, correlation of tissue composition (lumen-side) with 
the underlying structure, and understanding the relationship between changes in fluorescent 
signal as a function of plaque intima thickness and/or its composition. Such analysis can be 
performed for every position or line of interest. 
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Fluorescence emission analysis revealed that different plaque compositions could be 
distinguished using lifetime values at critical emission wavelength bands. The spectroscopic 
parameters were sensitive to the compositional changes in ratio of plaque fluorophores: 
elastin, collagen, and lipids as well as the progression of atherosclerosis. For example, in Fig. 
2, the lifetimes in ROI-1 and 3 were similar since the tissue type in these regions were both 
intimal thickening, where the fluorescence originated from the mixture of a small amount of 
collagen in the thin intimal layer and elastin in the medial layer as confirmed by 
histopathology. The lifetime in ROI-3 was slightly longer than ROI-1 due to the greater 
amount of collagen in ROI-3. The average lifetime of the fibrotic plaque in ROI-4 was 48% 
longer than the intimal thickening composition from ROI-1 because the average lifetime in 
ROI 4 was dominated by collagen fluorescence (3.0-4.0 ns) that has longer average lifetime 
than elastin (2.0-2.5 ns) [24]. Multiple features were observed in ROI-2 (rich in collagen and 
lipids) and the shorter average fluorescence lifetime of ROI-2 relative to the fibrotic plaque in 
ROI-4 denoted the contribution of the short lifetime of lipid components (0.5-1 ns) to the 
overall fluorescence decay [24]. The fluorescence features identified here are in agreement 
with previously reported extensive TRFS studies of carotid plaques [23,25] and underscore 
the role of fluorescence lifetime measurements in the evaluation of biochemical features in 
plaque intima. 
UBM cannot only be used to complement the TRFS data at the surface of the plaque, but 
can also provide structural features at locations beyond the UV light penetration depth. 
Furthermore, calcification was non-fluorescent at the excitation wavelength of 337 nm and 
cannot be detected by TRFS only, while UBM was sensitive to calcification (e.g. Fig. 2 ROI-
2) and therefore enable detection of calcified regions within plaques. The use of UBM 
provides a number of advantages that can be exploited in future catheter implementations. For 
example, the UBM image resolution can be improved by using higher frequency transducers 
(i.e. 60-70 MHz) with a spatial resolution of ~20 µm. At the same time, the penetration depth 
can still reach 3 to 4 mm as compared to the penetration depth of OCT which is usually less 
than 2 mm [2]. Plaque evaluation and feature extraction can be achieved not only by 
analyzing directly the gray scale B-mode images, but also by accessing the radiofrequency 
(RF) ultrasonic data which allowed for tissue composition characterization [26]. 
For PAI modality, a careful analysis of histological areas corresponding to distinct levels 
of photoacoustic signal intensity showed that the signal originating from lipid/macrophage 
regions was lower when compared with that originating from dense-collagen fibrous. These 
results are consistent with previous reports, showing the potential of PAI to resolve volumes 
defined by lipids/macrophages since this exhibits low optical absorption properties when 
compared to collagen-rich areas at the wavelength of 532 nm [12,27]. We hypothesized that 
the fibrotic or calcific regions were highly scattering and can result in an increase of local 
fluence, and therefore the magnitude of photoacoustic signals [27]. These results were 
observed consistently in all specimens/cross-sections [i.e. “hot spot” areas in Fig. 2(c) and 
Fig. 3(c)]. While additional studies (such as spectroscopic PAI) are required to confirm the 
role of lipids, different types of collagens, and elastin in the photoacoustic signal, the mapping 
of optical absorption properties in the PAI images was indicative of the physiological and 
pathological conditions of the tissue. As a result, a comprehensive assessment of the plaque 
including compositional, anatomical, and functional imaging at high resolution became 
possible through the combined TRFS/FLIM-UBM-PAI technique described here. 
While the multimodal probe (single-fiberoptic and single-ultrasonic transducer) used in 
current study is not feasible for intravascular applications, current results establish the 
framework for future intravascular implementation. The arterial wall scanning can be 
achieved using a combined catheter probe through a radial scanning rather than a linear 
scanning as depicted here. All the knowledge generated from the UBM and PAI subsystems 
including image processing, feature extraction, and coregistration with fluorescence data can 
be translated to IVUS and intravascular photoacoustic imaging (IVPA). Specifically, the value 
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of TRFS/FLIM for continuous radial recording and synergistic radial FLIM, IVUS, and IVPA 
recording during a catheter pull-back in the axial direction can be demonstrated based on the 
expertise acquired in this study [28]. 
In conclusion, current results successfully demonstrate our ability to acquire rigid-linked 
multimodal data (FLIM, UBM, and PAI) that allows for direct data co-registration. 
Specifically, fluorescence lifetime images in multiple spectral bands mapped the areas 
occupied by varying biochemical compositions (i.e. fibrotic, lipidic, elastin-rich, etc.) and 
provided the opportunity for enhanced detection of critical arterial wall pathologies. Two high 
resolution imaging techniques (UBM and PAI) were able to provide specific anatomical and 
functional images of the plaques (cross-section) and overcome the limited penetration depth 
of the TRFS/FLIM approach. A range of signal and image processing tools were implemented 
and tested for the analysis of the multimodal data obtained from atherosclerotic plaques. 
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